A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE

Show other versions (1)

Translation articles: <p>G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi «A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure» J Am Coll Cardiol <s...

Full description

Bibliographic Details
Main Authors:	G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	ингибиторы ангиотензинпревращающего фермента блокаторы рецепторов ангиотензина клинические события
Online Access:	http://www.rpcardio.ru/jour/article/view/287

Similar Items

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT
by: S. Yu. Martsevich
Published: (2015-09-01)

THE EFFICACY OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANTAGONISTS OF THE RECEPTORS OF THE 1ST TYPE OF ANGIOTENSIN II IN PATIENTS WITH CORONARY ARTERY DISEASE POSTINFARCTION CARDIOSCLEROSIS COMBINED WITH DIABETES MELLITUS TYPE 2 AND ARTERIAL HYPERTENSION
by: Zarina Vyacheslavovna Bitarovа, et al.
Published: (2016-07-01)

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
by: L. N. Malay, et al.
Published: (2016-01-01)

ДИСФУНКЦИЯ ПОЧЕК КАК ПРЕДИКТОР ПРОГРЕССИРОВАНИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
by: О. В. Заблоцкая, et al.
Published: (2023-09-01)

Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny
by: M V Shestakova
Published: (2006-03-01)

ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN ACUTE MYOCARDIAL INFARCTION: WHEN TO START THERAPY AND WHICH DRUG TO USE?
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

Clinical efficacy of AT1-receptors of angiotensin II valsartan in the pharmacotherapy of patients with arterial hypertension and chronic heart failure
by: A K Starodubtsev, et al.
Published: (2010-12-01)

Angiotensin II receptor blockers and cardiorenal risk management: Irbesartan status
by: V. V. Fomin
Published: (2013-12-01)

Sakharnyy diabet i arterial'naya gipertoniya: kakovy preparaty pervogo ryada vybora?
by: M V Shestakova
Published: (2005-03-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Vozmozhnosti obespecheniya nefroprotektsii na fone blokady retseptorov angiotenzina II kandesartanom u bol'nykh arterial'noy gipertoniey
by: N M Chikhladze, et al.
Published: (2004-03-01)

Primenenie ingibitorov angiotenzinprevrashchayushchego fermenta v lechenii arterial'noy gipertonii
by: A S Galyavich
Published: (2006-06-01)

A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE
by: G. Savarese, et al.
Published: (2015-09-01)

Farmakologicheskaya blokada angiotenzinovykh retseptorov v lechenii arterial'noy gipertenzii: ot saralazina do sartanov
by: Viktor Viktorovich Fomin, et al.
Published: (2013-09-01)

The choice of combination antihypertensive therapy in patients with type 2 diabetes
by: O. A. Koshelskaya, et al.
Published: (2015-12-01)

THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION
by: D. B. Nebieridze, et al.
Published: (2015-12-01)

Current and future use of angiotensin II receptor blockers in patients with COVID-19
by: A. V. Matveev, et al.
Published: (2020-10-01)

Effektivnoe i bezopasnoe ispol'zovanie perindoprila v doze 8 mg v kachestve startovogo lecheniya bol'nykh arterial'noy gipertoniey v usloviyakh statsionara (po rezul'tatam issledovaniya DOMINANTA)
by: O D Ostroumova, et al.
Published: (2006-06-01)

POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK
by: Z M. Sizova
Published: (2015-09-01)

FREE-RADICAL OXIDATION ACTIVITY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITHOUT Q WAVE TREATED WITH EPROSARTAN OR ENALAPRIL ADDITIONALLY TO THE BASIC THERAPY
by: O. G. Zaylobidinov, et al.
Published: (2016-01-01)

IZUChENIE PLEYOTROPNYKh EFFEKTOV V-ADRENOBLOKATOROV I INGIBITOROV APF NA KOSTNUYu TKAN'
by: I A SKRIPNIKOVA, et al.
Published: (2014-12-01)

КЛИНИЧЕСКИЕ ОСОБЕННОСТИ И ПОДХОДЫ К МЕДИКАМЕНТОЗНОЙ ТЕРАПИИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У ПАЦИЕНТОВ СТАРШЕГО ВОЗРАСТА
by: Дмитрий Дмитриевич Зотов, et al.
Published: (2022-01-01)

ADVANTAGES OF COMBINATION THERAPY OF HYPERTENSION WITH CALCIUM CHANNEL BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN PATIENTS WITH IMPAIRED RENAL FUNCTION
by: N. A. Dzhaiani
Published: (2015-09-01)

Kompleksnaya otsenka elasticheskikh svoystv i reaktivnosti intrakranial'nykh i perifericheskikh arteriy u patsientov s gipertonicheskoy bolezn'yu
by: P A Lebedev, et al.
Published: (2006-03-01)

Choosing antihypertensive drug for the treatment of hypertension
by: O. D. Ostroumova, et al.
Published: (2013-12-01)

NEW ANTIPLATELET DRUGS (PART 1)
by: A. B. Sumarokov
Published: (2016-01-01)

Effect of long-term therapy with AT1angiotensin II receptor blockers in combination with aldosterone receptor inhibitor on ischemic myocardial remodelling and chronic heart failure
by: AT Teplyakov, et al.
Published: (2014-12-01)

СОВРЕМЕННЫЕ ВОЗМОЖНОСТИ МЕДИКАМЕНТОЗНОЙ КОРРЕКЦИИ ЭНДОТЕЛИАЛЬНОЙ ДИСФУНКЦИИ У ПАЦИЕНТОВ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА В ИНТРАОПЕРАЦИОННОМ И РАННЕМ ПОСЛЕОПЕРАЦИОННОМ ПЕРИОДЕ ПОСЛЕ РЕВАСКУЛЯРИЗАЦИИ МИОКАРДА
by: R. E. Yakubtsevich, et al.
Published: (2022-03-01)

Polimorfizm gena angiotenzinprevrashchayushchego fermenta pri sakharnom diabete 1 tipa u detey Sibiri
by: E I Kondrat'eva, et al.
Published: (2001-12-01)

Cardiometabolic properties of telmisartan: new perspectives for use
by: O. M. Drapkina, et al.
Published: (2015-12-01)

Current approach to antihypertensive therapy
by: M. V. Kuznetsova
Published: (2015-12-01)

IRBESARTAN IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Pharmacogenetics in treatment of anthracycline-induced cardiotoxicity in women without prior cardiovascular diseases
by: E. V. Grakova, et al.
Published: (2023-01-01)

Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka
by: I E Chazova, et al.
Published: (2006-03-01)

Kombinirovannaya terapiya ingibitorom angiotenzinprevrashchayushchego fermenta i diuretikom
by: I E Chazova, et al.
Published: (2006-06-01)

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
by: L. N. Chikhireva, et al.
Published: (2015-12-01)

PREVALENCE AND STRUCTURE OF CEREBROVASCULAR COMPLICATIONS OF ARTERIAL HYPERTENSION IN UZBEK PATIENTS WITH VARIOUS ANGIOTENSIN-CONVERTING ENZYME AND APOLIPOPROTEINE E. GENE POLYMORPHISMS
by: N. U. Makhkamova, et al.
Published: (2012-06-01)

КЛИНИЧЕСКОЕ ПРИМЕНЕНИЕ КВАДРОПРИЛА У БОЛЬНЫХ АРТЕРИАЛЬНОЙ ГИПЕРТОНИЕЙ В СОЧЕТАНИИ С ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНЬЮ ЛЕГКИХ
Published: (2006-12-01)

SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
by: K. A. Gyamdzhyan, et al.
Published: (2015-12-01)

In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure
by: I. V. Zhirov, et al.
Published: (2015-12-01)